Table 3. Patient mortality outcomes and relationships of travelling time from home to GP, cancer diagnosis centre and cancer treatment centre.
Outcome=mortality to 1 year | ||||||
Travelling time (min) | <5.0 | 5.0–9.9 | 10.0–14.9 | >15.0 | Islands | |
Time from home to GP practice | N | 5798 | 2824 | 961 | 711 | 847 |
N event (%) | 1308 (22.6) | 571 (20.2) | 173 (18.0) | 127 (17.9) | 187 (22.1) | |
Unadjusted HR (95% CI) | 1.00 | 0.89 (0.80–0.98) | 0.77 (0.66–0.91) | 0.76 (0.63–0.91) | 0.98 (0.84–1.14) | |
Adjusteda HR (95% CI) | 1.00 | 0.90 (0.81–1.01) | 0.99 (0.84–1.19) | 0.76 (0.62–0.91) | 0.98 (0.82–1.16) | |
Travelling time (min) | <15.0 | 15.0–29.9 | 30.0–59.9 | >60.0 | Islands | |
Time from home to cancer diagnosis centre | N | 4878 | 2094 | 2178 | 1144 | 847 |
N event (%) | 949 (19.4) | 436 (20.8) | 488 (22.4) | 306 (26.7) | 187 (22.1) | |
Unadjusted HR (95% CI) | 1.00 | 1.08 (0.96–1.20) | 1.16 (1.04–1.29) | 1.43 (1.26–1.63) | 1.16 (0.99–1.35) | |
Adjusteda HR (95% CI) | 1.00 | 1.06 (0.93–1.21) | 1.20 (1.05–1.37) | 1.15 (0.98–1.35) | 1.14 (0.95–1.37) | |
Time from home to cancer treatment centre | N | 3704 | 1605 | 2269 | 2716 | 847 |
N event (%) | 812 (21.9) | 298 (18.6) | 456 (20.1) | 613 (22.6) | 187 (22.1) | |
Unadjusted HR (95% CI) | 1.00 | 0.82 (0.72–0.94) | 0.90 (0.80–1.01) | 1.03 (0.93–1.15) | 1.01 (0.86–1.19) | |
Adjusteda HR (95% CI) | 1.00 | 1.04 (0.89–1.22) | 1.21 (1.05–1.39) | 1.19 (1.04–1.36) | 1.17 (0.97–1.41) | |
Outcome=cancer-specific mortality to 1 year | ||||||
Travelling time (min) | <5.0 | 5.0–9.9 | 10.0–14.9 | >15.0 | Islands | |
Time from home to GP practice | N | 5798 | 2824 | 961 | 711 | 847 |
N event (%) | 1175 (20.3) | 517 (18.3) | 162 (16.9) | 117 (16.5) | 164 (19.4) | |
Unadjusted HR (95% CI) | 1.00 | 0.89 (0.81–0.99) | 0.81 (0.69–0.95) | 0.78 (0.64–0.94) | 0.96 (0.81–1.13) | |
Adjusteda HR (95% CI) | 1.00 | 0.91 (0.81–1.02) | 1.04 (0.87–1.25) | 0.75 (0.61–0.92) | 0.94 (0.79–1.13) | |
Travelling time (min) | <15.0 | 15.0–29.9 | 30.0–59.9 | >60.0 | Islands | |
Time from home to cancer diagnosis centre | N | 4878 | 2094 | 2178 | 1144 | 847 |
N event (%) | 847 (17.4) | 392 (18.7) | 447 (20.5) | 285 (24.9) | 164 (19.4) | |
Unadjusted HR (95% CI) | 1.00 | 1.08 (0.96–1.22) | 1.19 (1.06–1.34) | 1.49 (1.31–1.71) | 1.14 (0.96–1.35) | |
Adjusteda HR (95% CI) | 1.00 | 1.06 (0.92–1.21) | 1.22 (1.06–1.40) | 1.16 (0.99–1.37) | 1.10 (0.91–1.33) | |
Time from home to cancer treatment centre | N | 3704 | 1605 | 2269 | 2716 | 847 |
N event (%) | 730 (19.7) | 271 (16.9) | 416 (18.3) | 554 (20.4) | 164 (19.4) | |
Unadjusted HR (95% CI) | 1.00 | 0.83 (0.73–0.96) | 0.91 (0.81–1.03) | 1.04 (0.93–1.16) | 0.99 (0.83–1.17) | |
Adjusteda HR (95% CI) | 1.00 | 1.04 (0.89–1.23) | 1.21 (1.05–1.41) | 1.18 (1.03–1.36) | 1.13 (0.92–1.37) |
Abbreviations: 95% CI=95% confidence interval; GP=general practitioner; HR=hazard ratio.
Adjusted for age, gender, urban/rural code 2, deprivation, urgency/referral status, cancer type, procedure type, Charlson comorbidity index (CCI) score, treatment type and metastatic cancer.